PetCure hits 10,000 treated pets as radiation access expands

PetCure Oncology says it has now treated 10,000 pets with radiation therapy since launching in 2015, a milestone the company is framing as evidence that advanced radiation oncology is becoming more accessible outside academic referral settings. In its January 7, 2026 announcement, PetCure said it now operates eight treatment centers nationwide and supports referrals with a team that includes 12 board-certified oncologists and eight supervising veterinarians. The company’s model centers on stereotactic radiosurgery and stereotactic radiation therapy, which can often be completed in one to three sessions rather than the 15 to 21 fractions historically associated with conventional protocols. (petcureoncology.com)

Why it matters: For veterinary professionals, the story is less about a round-number milestone and more about referral access. PetCure’s growth reflects a broader shift in companion animal oncology toward shorter-course, high-precision radiation protocols that can reduce anesthetic events and make travel more feasible for pet parents. That matters in a market where access to radiation oncology remains uneven, and where industry observers and PetCure’s own clinical leadership have argued that geography, treatment burden, and the small number of veterinary radiation oncologists continue to limit care. (vet-advantage.com)

What to watch: Watch whether PetCure’s next phase is defined less by patient-count milestones and more by new site openings, including its planned Seattle launch with the Sirius radiation platform, plus any peer-reviewed outcomes data that further validate its high-volume model. (dvm360.com)